PJSC Pharmstandard Release: The Company Received Mandatory Tender Offer To Acquire Ordinary Shares

PJSC Pharmstandard (LSE: PHST IL, ????: PHST RU) (hereinafter the “Company” or “Pharmstandard”) announces the receipt of a mandatory tender offer to acquire ordinary shares of the Company. On June 22, 2016 the Company received from Augment Investments Limited, its controlling shareholder, a Russian law governed mandatory tender offer (the “Offer”) to acquire for cash ordinary shares of the Company from the remaining shareholders at a purchase price of RUB 1,028 per ordinary share.